27 related articles for article (PubMed ID: 9826945)
1. Nontargeted analysis of DNA adducts by mass-tag MS: reaction of p-benzoquinone with DNA.
Wang P; Gao J; Li G; Shimelis O; Giese RW
Chem Res Toxicol; 2012 Dec; 25(12):2737-43. PubMed ID: 23113579
[TBL] [Abstract][Full Text] [Related]
2. Ultraperformance Liquid Chromatography Tandem Mass Spectrometry Method To Determine Formaldehyde Hemoglobin Adducts in Humans as Biomarker for Formaldehyde Exposure.
Yang M; Ospina M; Tse C; Toth S; Caudill SP; Vesper HW
Chem Res Toxicol; 2017 Aug; 30(8):1592-1598. PubMed ID: 28662331
[TBL] [Abstract][Full Text] [Related]
3. Interaction of
Ghosh A; Banerjee S; Mitra A; Muralidharan M; Roy B; Banerjee R; Mandal AK; Chatterjee IB
Toxicol Rep; 2016; 3():295-305. PubMed ID: 28959550
[TBL] [Abstract][Full Text] [Related]
4. Quo vadis blood protein adductomics?
Sabbioni G; Day BW
Arch Toxicol; 2022 Jan; 96(1):79-103. PubMed ID: 34773488
[TBL] [Abstract][Full Text] [Related]
5. Refinement of a Methodology for Untargeted Detection of Serum Albumin Adducts in Human Populations.
Preston GW; Plusquin M; Sozeri O; van Veldhoven K; Bastian L; Nawrot TS; Chadeau-Hyam M; Phillips DH
Chem Res Toxicol; 2017 Dec; 30(12):2120-2129. PubMed ID: 29092396
[TBL] [Abstract][Full Text] [Related]
6. Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future.
Sabbioni G; Turesky RJ
Chem Res Toxicol; 2017 Jan; 30(1):332-366. PubMed ID: 27989119
[TBL] [Abstract][Full Text] [Related]
7. The use of biomonitoring data in exposure and human health risk assessment: benzene case study.
Arnold SM; Angerer J; Boogaard PJ; Hughes MF; O'Lone RB; Robison SH; Schnatter AR
Crit Rev Toxicol; 2013 Feb; 43(2):119-53. PubMed ID: 23346981
[TBL] [Abstract][Full Text] [Related]
8. Albumin adducts of electrophilic benzene metabolites in benzene-exposed and control workers.
Lin YS; Vermeulen R; Tsai CH; Waidyanatha S; Lan Q; Rothman N; Smith MT; Zhang L; Shen M; Li G; Yin S; Kim S; Rappaport SM
Environ Health Perspect; 2007 Jan; 115(1):28-34. PubMed ID: 17366815
[TBL] [Abstract][Full Text] [Related]
9. Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans.
Richter E; Branner B
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Oct; 778(1-2):49-62. PubMed ID: 12376116
[TBL] [Abstract][Full Text] [Related]
10. Protein Adductomics: Methodologies for Untargeted Screening of Adducts to Serum Albumin and Hemoglobin in Human Blood Samples.
Carlsson H; Rappaport SM; Törnqvist M
High Throughput; 2019 Mar; 8(1):. PubMed ID: 30857166
[TBL] [Abstract][Full Text] [Related]
11. A new assay for albumin and hemoglobin adducts of 1,2- and 1,4-benzoquinones.
Waidyanatha S; Yeowell-O'Connell K; Rappaport SM
Chem Biol Interact; 1998 Sep; 115(2):117-39. PubMed ID: 9826945
[TBL] [Abstract][Full Text] [Related]
12. Stability of hemoglobin and albumin adducts of benzene oxide and 1,4-benzoquinone after administration of benzene to F344 rats.
Troester MA; Lindstrom AB; Kupper LL; Waidyanatha S; Rappaport SM
Toxicol Sci; 2000 Mar; 54(1):88-94. PubMed ID: 10746935
[TBL] [Abstract][Full Text] [Related]
13. Production of benzoquinone adducts with hemoglobin and bone-marrow proteins following administration of [13C6]benzene to rats.
McDonald TA; Waidyanatha S; Rappaport SM
Carcinogenesis; 1993 Sep; 14(9):1921-5. PubMed ID: 8403219
[TBL] [Abstract][Full Text] [Related]
14. Protein adducts of 1,4-benzoquinone and benzene oxide among smokers and nonsmokers exposed to benzene in China.
Yeowell-O'Connell K; Rothman N; Waidyanatha S; Smith MT; Hayes RB; Li G; Bechtold WE; Dosemeci M; Zhang L; Yin S; Rappaport SM
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):831-8. PubMed ID: 11489749
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]